incTANK Ventures Joins a Nationwide Network Working to Accelerate Transformative Health Solutions
Cambridge, MA, December 10, 2024 – incTANK Ventures, an early stage investment company, announced today that it was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H).
Based in the Greater Boston area and managed by VentureWell, the Investor Catalyst Hub seeks to accelerate the commercialization of groundbreaking and accessible biomedical solutions. It utilizes an innovative hub-and-spoke model designed to reach a wide range of nonprofit organizations and Minority-Serving Institutions, with the ultimate aim of delivering scalable healthcare outcomes for all Americans.
incTANK Ventures is focused on university-sourced biotech startups in the Boston area,” noted Karl Ruping, Senior Managing Partner. “We have grown along with the regional ecosystem, leveraging government grant mechanisms, academic innovation, and industry partnerships. The incTANK team is excited to join the expanding ARPA-H Investor Catalyst Hub to advance the innovation network for patient needs.
incTANK Ventures joins a dynamic nationwide network of organizations aligned to ARPA-H’s overarching mission to improve health outcomes through the following research focus areas: health science futures, proactive health, scalable solutions, and resilient systems. Investor Catalyst Hub spokes represent a broad spectrum of expertise, geographic diversity, and community perspectives.
Our spoke network embodies a rich and representative range of perspectives and expertise,” said Mark Marino, Vice President of Growth Strategy and Development for VentureWell and Project Director for the Investor Catalyst Hub. “Our spokes comprise a diverse network that will be instrumental in ensuring that equitable health solutions reach communities across every state and tribal nation.
As an Investor Catalyst Hub spoke, incTANK Ventures gains access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. Spoke membership also offers opportunities to provide input on ARPA-H challenge areas and priorities, along with access to valuable networking opportunities and a robust resource library.
The spoke network will continue to grow as the Investor Catalyst Hub expands its efforts, with applications being selected on a rolling basis. Interested organizations can visit https://investorcatalysthub.org/ to learn more or submit a membership application.
About incTANK Ventures
incTANK Ventures is an early stage investor group focused on university-sourced biotech startups with talented founders, core intellectual property assets, and global market opportunities. We work with leading research institutes and cutting-edge investigators with deep domain expertise to build exciting ventures that provide novel solutions for patient needs. The incTANK team is comprised of experienced founders, industry leaders, and international investors who have assembled a portfolio of successful ventures spanning medical devices, connected health and computational drug design. Visit us at www.inctank.com.
For more, see the incTANK press release.
Tiba Biotech announced its new partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), through initiation of an EZ-BAA contract to develop groundbreaking therapeutics against influenza.
We are excited to receive this BARDA award, which will advance Tiba’s innovative approach to combating influenza and other viral threats. We believe our technology has the potential to transform the landscape of RNA therapeutics..
— Jusdave Chahal, co-founder and lead investigator of the project
For more, see the Tiba Biotech press release.
Recent Comments